Bullboard - Stock Discussion Forum Pyxis Oncology Inc PYXS

Healthcare Biotechnology

Pyxis Oncology, Inc. is a clinical-stage company focused on developing therapeutics to target difficult-to-treat cancers. The Company is building therapeutics that hold the potential for mono and combination therapies. Its clinical program portfolio includes PYX-201, PYX-106 and PYX-107. PYX-201, an antibody-drug conjugate (ADC) that targets Extradomain-B Fibronectin within the tumor stroma... see more

Add To Watchlist

NDAQ:PYXS - Post Discussion

Pyxis Oncology Inc > Pyxis Oncology to Host In-Person (NYC) and Virtual Investor

View:

Post by whytestocks on Nov 11, 2024 12:02pm

Pyxis Oncology to Host In-Person (NYC) and Virtual Investor

JUST IN: $PYXS Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201BOSTON, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced that it will host an in-person and virtual investor event to discuss preliminary data fr...PYXS - Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201